An interventional study of Speech Motor Chaining without Biofeedback and Biofeedback in Childhood Apraxia of Speech, sponsored by Syracuse University. Completed at 1 site in United States. Open to participants aged 9 Years to 17 Years. Per ClinicalTrials.gov, last updated 2023-06-22.
Sponsored by Syracuse University · Not applicable, Interventional, and Treatment
The study will test two modifications to speech therapy for 40 school-age children with childhood apraxia of speech to determine how to improve treatment outcomes. The study will compare treatment that includes real-time visual feedback of the tongue during speech using ultrasound vs traditional therapy that does not include ultrasound visual feedback. Additionally, some children will be treated with a traditional schedule of 2 sessions per week, whereas others will be provided with treatment that begins with intensive training (10 hours of therapy in one week) and progresses to a more distributed treatment schedule.
Childhood apraxia of speech is a developmental speech sound disorder that may lead to persisting speech errors, often despite years of treatment. Such impairments may lead to social, academic, and vocational limitations. Thus, there is a need to explore alternate treatment approaches. This study will explore how to improve speech sound production in school-age children with CAS by modifying a standard speech therapy program. Two adaptations to speech therapy will be tested in a 2 x 2 randomized group design.
In Aim 1, a standard treatment schedule of 2 one-hour sessions per week will be compared against a treatment sequence beginning with an intensive therapy schedule (10 hrs of treatment in one week), which will then transition to a more distributed practice schedule. This treatment modification is intended to minimize erred practice between training sessions in the early stages of learning, then foster generalization through increased time between practice sessions.
In Aim 2, a standard treatment that includes only verbal feedback to the client during speech practice will be compared against a treatment sequence that initially includes real-time ultrasound visual feedback of the tongue during speech, which will be faded over the course of treatment. Ultrasound visual feedback is designed to train articulatory movements. It may enhance children's understanding of the articulatory goals of speech movement patterns by comparing executed tongue movements with intended movements. Prior case reports and single subject experimental designs have shown that speech sound production may be enhanced by including ultrasound visual feedback, although no prior randomized group studies have been conducted.
Beside these modifications, the other aspects of treatment will be held constant. Outcomes will be evaluated by tracking changes in percent consonants correct from a large speech sample, scored by individuals who are blind to treatment status. The four groups will be compared to determine the extent to which speech sound therapy can be enhanced through a treatment sequence that begins with intensive practice and/or with ultrasound visual feedback.
Exclusion Criteria:
Sequenced biofeedback Mass Practice--\> Distributed Scheduling
Behavioral: Biofeedback · Behavioral: Massed --> Distributed Practice
Speech Motor Chaining with no biofeedback. 2 sessions/wk for 10 weeks
Behavioral: Speech Motor Chaining without Biofeedback · Behavioral: Distributed Practice
Sequenced biofeedback, 2 sessions/wk for 10 weeks
Behavioral: Biofeedback · Behavioral: Distributed Practice
Speech Motor Chaining with no biofeedback. Mass Practice--\> Distributed Scheduling
Behavioral: Speech Motor Chaining without Biofeedback · Behavioral: Massed --> Distributed Practice
These procedures target sound sequences (consonant-vowel, consonant-consonant, or vowel-consonant). Sessions begin with Pre-practice to elicit the target sounds, with verbal cueing and shaping strategies. The Practice component then includes chaining that is response-contingent. Participants practice in blocks of 6 consecutive trials beginning at the syllable level. If 5/6 are correct, the participant advances to monosyllabic word practice, then multisyllabic word practice, phrase practice, and sentence practice (with the target syllable embedded within each level of complexity). If fewer than 5/6 trials are correct, a different syllable with the target sound pattern is practiced next. Verbal feedback is faded from 5 of 6 trials at the syllable level to only 3 of 6 trials at the sentence level. For more description, see http://speechproductionlab.syr.edu/Resources%20for%20Researchers.html
Real-time images of the tongue are made available using ultrasound placed beneath the chin. Participants practice speech movements and can be cued to modify their tongue shape or position to achieve clearer speech. Practice structure is similar to the Speech Motor Chaining procedures, but with the addition of a visual reference.
2 sessions per week for 10 weeks
Week 1: 10 hours of treatment Week 2: 3 hours of treatment Week 3: 3 hours of treatment Week 4: 2 hours of treatment Week 5: 2 hours of treatment
Speech Sound Accuracy
Percent consonants correct for target sounds: The primary outcome measure was percent correct for each participant's target sound-positions in untreated phrase. Participants imitated 20 pre-recorded phrases, each containing the target sound pattern 2 times per stimulus (e.g., for /l/ onset, "leave the location"), resulting in 40 attempts at each sound-position. For each session, 3 transcribers independently transcribed in Phon software (Hedlund \& Rose, 2022) and accuracy was averaged across transcribers. Instances where IPA symbols for the Actual transcription differed from the Target transcription was scored as incorrect.
Time frame: 10 weeks from the start of treatment
| Milestone | Biofeedback, Massed->Distributed, Face-to-Face | No Biofeedback, Distributed, Face-to-Face | Biofeedback, Distributed, Face-to-Face | No Biofeedback, Massed-> Distributed, Face-to-Face | No Biofeeedback, Distributed, Telepractice | No Biofeedback, Massed->Distributed, Telepractice |
|---|---|---|---|---|---|---|
| Started | 9 | 9 | 10 | 9 | 10 | 9 |
| Completed | 7 | 7 | 8 | 8 | 9 | 9 |
| Not completed | 2 | 2 | 2 | 1 | 1 | 0 |
Percent consonants correct for target sounds: The primary outcome measure was percent correct for each participant's target sound-positions in untreated phrase. Participants imitated 20 pre-recorded phrases, each containing the target sound pattern 2 times per stimulus (e.g., for /l/ onset, "leave the location"), resulting in 40 attempts at each sound-position. For each session, 3 transcribers independently transcribed in Phon software (Hedlund \& Rose, 2022) and accuracy was averaged across transcribers. Instances where IPA symbols for the Actual transcription differed from the Target transcription was scored as incorrect.
| Percent correct | Biofeedback, Massed->Distributed, Face-to-Face | No Biofeedback, Distributed, Face-to-Face | Biofeedback, Distributed, Face-to-Face | No Biofeedback, Massed-> Distributed, Face-to-Face | No Biofeeedback, Distributed, Telepractice | No Biofeedback, Massed->Distributed, Telepractice |
|---|---|---|---|---|---|---|
| Speech Sound Accuracy | 54.1 ± 13.5 | 32.5 ± 14.1 | 26.8 ± 10.2 | 42.1 ± 11.1 | 32.50 ± 7.0 | 43.0 ± 7.7 |
Collected over 5 weeks and 10 weeks after the start of treatment. Non-serious events are listed at a 0% frequency threshold.
| Group | Deaths | Serious | Other |
|---|---|---|---|
| Biofeedback, Massed->Distributed, Face-to-Face | 0/9 (0%) | 0/9 (0%) | 0/9 (0%) |
| No Biofeedback, Distributed, Face-to-Face | 0/9 (0%) | 0/9 (0%) | 0/9 (0%) |
| Biofeedback, Distributed, Face-to-Face | 0/10 (0%) | 0/10 (0%) | 0/10 (0%) |
| No Biofeedback, Massed-> Distributed, Face-to-Face | 0/9 (0%) | 0/9 (0%) | 0/9 (0%) |
| No Biofeeedback, Distributed, Telepractice | 0/10 (0%) | 0/10 (0%) | 0/10 (0%) |
| No Biofeedback, Massed->Distributed, Telepractice | 0/9 (0%) | 0/9 (0%) | 0/9 (0%) |
| Age, Continuous(years) | Biofeedback, Massed->Distributed, Face-to-Face | No Biofeedback, Distributed, Face-to-Face | Biofeedback, Distributed, Face-to-Face | No Biofeedback, Massed-> Distributed, Face-to-Face | No Biofeeedback, Distributed, Telepractice | No Biofeedback, Massed->Distributed, Telepractice | Total |
|---|---|---|---|---|---|---|---|
| Mean | 10.31 ± 1.0 | 10.85 ± 1.7 | 12.2 ± 2.1 | 10.0 ± 1.1 | 11.05 ± 2.4 | 11.16 ± 2.3 | 10.96 ± 1.9 |
| Sex: Female, Male(Participants) | Biofeedback, Massed->Distributed, Face-to-Face | No Biofeedback, Distributed, Face-to-Face | Biofeedback, Distributed, Face-to-Face | No Biofeedback, Massed-> Distributed, Face-to-Face | No Biofeeedback, Distributed, Telepractice | No Biofeedback, Massed->Distributed, Telepractice | Total |
|---|---|---|---|---|---|---|---|
| Female | 3 | 3 | 2 | 3 | 4 | 2 | 17 |
| Male | 6 | 6 | 8 | 6 | 6 | 7 | 39 |
| Ethnicity (NIH/OMB)(Participants) | Biofeedback, Massed->Distributed, Face-to-Face | No Biofeedback, Distributed, Face-to-Face | Biofeedback, Distributed, Face-to-Face | No Biofeedback, Massed-> Distributed, Face-to-Face | No Biofeeedback, Distributed, Telepractice | No Biofeedback, Massed->Distributed, Telepractice | Total |
|---|---|---|---|---|---|---|---|
| Hispanic or Latino | 3 | 1 | 2 | 0 | 0 | 3 | 9 |
| Not Hispanic or Latino | 6 | 8 | 8 | 9 | 9 | 6 | 46 |
| Unknown or Not Reported | 0 | 0 | 0 | 0 | 1 | 0 | 1 |
| Race (NIH/OMB)(Participants) | Biofeedback, Massed->Distributed, Face-to-Face | No Biofeedback, Distributed, Face-to-Face | Biofeedback, Distributed, Face-to-Face | No Biofeedback, Massed-> Distributed, Face-to-Face | No Biofeeedback, Distributed, Telepractice | No Biofeedback, Massed->Distributed, Telepractice | Total |
|---|---|---|---|---|---|---|---|
| American Indian or Alaska Native | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Asian | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Native Hawaiian or Other Pacific Islander | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Black or African American | 0 | 0 | 1 | 0 | 0 | 0 | 1 |
| White | 9 | 8 | 8 | 7 | 6 | 7 | 45 |
| More than one race | 0 | 1 | 1 | 2 | 3 | 2 | 9 |
| Unknown or Not Reported | 0 | 0 | 0 | 0 | 1 | 0 | 1 |
| Region of Enrollment(participants) | Biofeedback, Massed->Distributed, Face-to-Face | No Biofeedback, Distributed, Face-to-Face | Biofeedback, Distributed, Face-to-Face | No Biofeedback, Massed-> Distributed, Face-to-Face | No Biofeeedback, Distributed, Telepractice | No Biofeedback, Massed->Distributed, Telepractice | Total |
|---|---|---|---|---|---|---|---|
| United States | 9 | 9 | 10 | 9 | 10 | 9 | 56 |
| Speech Sound Accuracy(Percent correct) | Biofeedback, Massed->Distributed, Face-to-Face | No Biofeedback, Distributed, Face-to-Face | Biofeedback, Distributed, Face-to-Face | No Biofeedback, Massed-> Distributed, Face-to-Face | No Biofeeedback, Distributed, Telepractice | No Biofeedback, Massed->Distributed, Telepractice | Total |
|---|---|---|---|---|---|---|---|
| Mean | 20.2 ± 7.3 | 21.2 ± 12.1 | 17.0 ± 4.3 | 23.2 ± 7.4 | 28.9 ± 8.1 | 35.5 ± 7.8 | 24.3 ± 7.8 |
Documents are hosted by the registry — open the source record to download them.
Plan to share: No
This study is completed, as verified in May 2023. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Syracuse University